» Articles » PMID: 31706453

Evaluation of Risk Prediction Models of Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis [MESA])

Overview
Journal Am J Cardiol
Date 2019 Nov 11
PMID 31706453
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Atrial fibrillation (AF) is prevalent and strongly associated with higher cardiovascular disease (CVD) risk. Machine learning is increasingly used to identify novel predictors of CVD risk, but prediction improvements beyond established risk scores are uncertain. We evaluated improvements in predicting 5-year AF risk when adding novel candidate variables identified by machine learning to the CHARGE-AF Enriched score, which includes age, race/ethnicity, height, weight, systolic and diastolic blood pressure, current smoking, use of antihypertensive medication, diabetes, and NT-proBNP. We included 3,534 participants (mean age, 61.3 years; 52.0% female) with complete data from the prospective Multi-Ethnic Study of Atherosclerosis. Incident AF was defined based on study electrocardiograms and hospital discharge diagnosis ICD-9 codes, supplemented by Medicare claims. Prediction performance was evaluated using Cox regression and a parsimonious model was selected using LASSO. Within 5 years of baseline, 124 participants had incident AF. Compared with the CHARGE-AF Enriched model (c-statistic, 0.804), variables identified by machine learning, including biomarkers, cardiac magnetic resonance imaging variables, electrocardiogram variables, and subclinical CVD variables, did not significantly improve prediction. A 23-item score derived by machine learning achieved a c-statistic of 0.806, whereas a parsimonious model including the clinical risk factors age, weight, current smoking, NT-proBNP, coronary artery calcium score, and cardiac troponin-T achieved a c-statistic of 0.802. This analysis confirms that the CHARGE-AF Enriched model and a parsimonious 6-item model performed similarly to a more extensive model derived by machine learning. In conclusion, these simple models remain the gold standard for risk prediction of AF, although addition of the coronary artery calcium score should be considered.

Citing Articles

Unveiling the Molecular Links Between Atrial Fibrillation and Atherosclerosis: Insights into Shared Pathogenesis and Ferroptosis Diagnostic Biomarkers.

Xu B, Li H, Chen H, Teng D, Gong L, Zhong L J Inflamm Res. 2024; 17:8813-8830.

PMID: 39559400 PMC: 11570537. DOI: 10.2147/JIR.S488288.


The Use of Artificial Intelligence for Detecting and Predicting Atrial Arrhythmias Post Catheter Ablation.

Lallah P, Laite C, Bangash A, Chooah O, Jiang C Rev Cardiovasc Med. 2024; 24(8):215.

PMID: 39076714 PMC: 11266764. DOI: 10.31083/j.rcm2408215.


Precise risk-prediction model including arterial stiffness for new-onset atrial fibrillation using machine learning techniques.

Kanegae H, Fujishiro K, Fukatani K, Ito T, Kario K J Clin Hypertens (Greenwich). 2024; 26(7):806-815.

PMID: 38850282 PMC: 11232446. DOI: 10.1111/jch.14848.


Artificial intelligence in the risk prediction models of cardiovascular disease and development of an independent validation screening tool: a systematic review.

Cai Y, Cai Y, Tang L, Wang Y, Gong M, Jing T BMC Med. 2024; 22(1):56.

PMID: 38317226 PMC: 10845808. DOI: 10.1186/s12916-024-03273-7.


Machine learning for atrial fibrillation risk prediction in patients with sleep apnea and coronary artery disease.

Silva C, Morillo C, Leite-Castro C, Gonzalez-Otero R, Bessani M, Gonzalez R Front Cardiovasc Med. 2022; 9:1050409.

PMID: 36568544 PMC: 9768180. DOI: 10.3389/fcvm.2022.1050409.


References
1.
Sinner M, Stepas K, Moser C, Krijthe B, Aspelund T, Sotoodehnia N . B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace. 2014; 16(10):1426-33. PMC: 4197895. DOI: 10.1093/europace/euu175. View

2.
Soliman E, Lopez F, ONeal W, Chen L, Bengtson L, Zhang Z . Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015; 131(21):1843-50. PMC: 4447576. DOI: 10.1161/CIRCULATIONAHA.114.014145. View

3.
Patton K, Ellinor P, Heckbert S, Christenson R, deFilippi C, Gottdiener J . N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation. 2009; 120(18):1768-74. PMC: 4132053. DOI: 10.1161/CIRCULATIONAHA.109.873265. View

4.
Heckbert S, Wiggins K, Blackshear C, Yang Y, Ding J, Liu J . Pericardial fat volume and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis and Jackson Heart Study. Obesity (Silver Spring). 2017; 25(6):1115-1121. PMC: 5445011. DOI: 10.1002/oby.21835. View

5.
Schnabel R, Larson M, Yamamoto J, Sullivan L, Pencina M, Meigs J . Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010; 121(2):200-7. PMC: 3224826. DOI: 10.1161/CIRCULATIONAHA.109.882241. View